<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://chl.alphagenics.co/blog/chl-exosomas-estetica-chile-isp-cosmetico-inyectable/</loc><news:news><news:publication><news:name>Alphagenics Chile</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>Exosomas en estética en Chile: el ISP solo permite uso tópico</news:title></news:news></url><url><loc>https://chl.alphagenics.co/blog/chl-polinucleotidos-pdrn-chile-isp-medicube-evidencia/</loc><news:news><news:publication><news:name>Alphagenics Chile</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>Polinucleótidos y PDRN en Chile: evidencia, ISP y Medicube</news:title></news:news></url><url><loc>https://chl.alphagenics.co/blog/chl-colageno-hidrolizado-chile-metaanalisis-suplementos-vacio-regulatorio/</loc><news:news><news:publication><news:name>Alphagenics Chile</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Colágeno hidrolizado en Chile: metaanálisis y vacío regulatorio</news:title></news:news></url><url><loc>https://chl.alphagenics.co/blog/chl-peptidos-senal-matrixyl-cremas-antiarrugas-isp/</loc><news:news><news:publication><news:name>Alphagenics Chile</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Péptidos señal en cremas antiarrugas en Chile: Matrixyl, ensayos y límite del ISP</news:title></news:news></url></urlset>
